Showing results (211-220 of 364) with videos related to

Sort By:
Pageof 37
Blood|January 10, 2008
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology GroupStella M Davies, Michael J Borowitz, Gary L Rosner, et al.
Cancer|January 31, 2018
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancerAnya Litvak, Bhavina Batukbhai, Stuart D Russell, et al.
JCO Oncology Practice|February 20, 2026
Same-Day Multidisciplinary Clinics for Patients With Newly Diagnosed Adult Solid Tumor Cancer: A Systematic ReviewJohn F Deeken, Wayne Pereanu, Raymond C Wadlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survivalJoseph R Sterbis, Chunling Gao, Bungo Furusato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863A P Venook, C Enders Klein, G Fleming, et al.
The Journal of Urology|September 18, 2020
A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at BiopsyIndu Kohaar, Yongmei Chen, Sreedatta Banerjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemiaDavid A Rizzieri, Adam J Bass, Gary L Rosner, et al.
Haematologica|January 29, 2016
Association of acute myeloid leukemia's most immature phenotype with risk groups and outcomesJonathan M Gerber, Joshua F Zeidner, Sarah Morse, et al.
The Journal of Urology|March 16, 2016
Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate CancerKhanh N Pham, Jennifer Cullen, Lauren M Hurwitz, et al.
Frontiers in Medicine|June 20, 2019
Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination TrialsChanning J Paller, Erich P Huang, Thomas Luechtefeld, et al.
Pageof 37